ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
EU - Europa 1.682
NA - Nord America 1.653
AS - Asia 864
SA - Sud America 47
AF - Africa 12
OC - Oceania 4
Totale 4.262
Nazione #
US - Stati Uniti d'America 1.631
IT - Italia 667
SG - Singapore 356
HK - Hong Kong 274
DE - Germania 248
RU - Federazione Russa 235
IE - Irlanda 200
SE - Svezia 106
ID - Indonesia 85
CN - Cina 67
GB - Regno Unito 65
BR - Brasile 41
FI - Finlandia 34
NL - Olanda 34
IN - India 22
CA - Canada 19
FR - Francia 17
AT - Austria 14
CZ - Repubblica Ceca 14
ES - Italia 11
PH - Filippine 8
TR - Turchia 8
IR - Iran 7
PK - Pakistan 6
VN - Vietnam 6
CH - Svizzera 5
MA - Marocco 5
UA - Ucraina 5
AU - Australia 4
IL - Israele 4
PT - Portogallo 4
AL - Albania 3
BD - Bangladesh 3
DK - Danimarca 3
EG - Egitto 3
IQ - Iraq 3
PL - Polonia 3
RO - Romania 3
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
HN - Honduras 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BE - Belgio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 4.262
Città #
Ann Arbor 345
Singapore 306
Hong Kong 273
Dublin 190
Frankfurt am Main 171
Milan 159
Chandler 124
Ashburn 121
New York 113
Santa Clara 105
Jakarta 73
Rome 47
Fairfield 42
Princeton 40
Seattle 35
London 31
Wilmington 29
Bologna 26
Altamura 25
Helsinki 25
Boardman 24
Munich 24
Nuremberg 24
Perugia 21
Verona 20
Parma 19
Lawrence 18
Woodbridge 17
San Diego 15
Washington 15
Florence 14
Houston 14
Shanghai 14
Cambridge 13
Palermo 10
Toronto 10
Pavia 9
Phoenix 9
Slough 9
Lappeenranta 8
São Paulo 8
Brno 7
Monza 7
Osasco 7
Andover 6
Assago 6
Beijing 6
Bergamo 6
Brescia 6
Chicago 6
Guangzhou 6
Madrid 6
Naples 6
Berlin 5
Boulogne-Billancourt 5
Carate Brianza 5
Hyderabad 5
Los Angeles 5
Magenta 5
Moscow 5
Prague 5
Pune 5
Vienna 5
Amsterdam 4
Canelli 4
Cesena 4
Hangzhou 4
Kocaeli 4
Ottawa 4
Padova 4
Tanza 4
Bari 3
Cairo 3
Cutro 3
Dallas 3
Durg 3
Ferrara 3
Giv‘atayim 3
Huizen 3
Iasi 3
Lissone 3
Lummi Island 3
Melzo 3
Messina 3
Norwalk 3
Osimo 3
Paris 3
Pescara 3
Piacenza 3
Pisa 3
Priocca 3
Québec 3
Ravenna 3
Redmond 3
Shenyang 3
Tirana 3
Triuggio 3
Wolfsburg 3
Aarhus 2
Ambāla 2
Totale 2.837
Nome #
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 338
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 174
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 166
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 162
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 158
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 127
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 117
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 115
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 110
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 98
A Multidatabase study of trajectories of antidepressant use in Italy 97
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 92
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 88
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 85
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 81
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 73
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 71
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 67
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 66
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 66
Azithromycin use and covid-19: a real-world observational study. 64
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 62
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 62
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 60
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 60
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 59
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 58
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 58
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 57
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 57
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 56
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 51
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 50
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 49
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 48
Epidemiology of SLE in Italy: an observational study using a primary care database 47
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 45
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 43
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 43
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 41
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 40
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 37
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 35
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 34
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 34
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 33
Editorial: Overcoming boundaries in public health: Advances in international and global health 33
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 32
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 32
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 32
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 32
The Burden of Chronic Heart Failure in Primary Care in Italy 31
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 31
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 30
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 30
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 30
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 30
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 29
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 29
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 28
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 28
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 28
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 28
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 28
Diabetes is associated with decreased migraine risk: A nationwide cohort study 27
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 27
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 27
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 27
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 27
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 26
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 26
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 26
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 26
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 25
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 25
Drug-induced Kounis syndrome: A matter of pharmacovigilance 24
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 24
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 19
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 17
Risk management and drug utilization research 12
Totale 4.560
Categoria #
all - tutte 27.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 6 1 2
2020/2021330 0 4 7 7 37 68 31 34 33 34 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20251.578 173 332 133 189 287 180 249 35 0 0 0 0
Totale 4.560